Replimune Group Inc (REPL)

Date: O: H: L: C: Vol:

Finanzdaten der Replimune Group Inc-Aktie (REPL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	17.53%56.28	68.25	73.34	71.87	84.29
Selling, General, and Administrative	15.53%21.92	18.97	-	-	-
Research and Development	30.26%34.37	49.28	52.32	53.14	57.88
Operating Income/Loss	17.53%-56.28	-68.25	-73.34	-71.87	-84.29
Nonoperating Income/Loss	44.70%-0.84	-1.52	-0.12	0.63	1.19
	18.12%-57.12	-69.77	-73.22	-70.93	-83.10
Attributable To Parent	18.12%-57.12	-69.77	-73.22	-70.93	-83.10
Available To Common Stockholders, Basic	18.12%-57.12	-69.77	-73.22	-70.93	-83.10
Basic Average Shares	8.58%105.18	96.86	-	92.19	91.92
Diluted Average Shares	8.58%105.18	96.86	-	92.19	91.92
Basic Earnings Per Share	25.00%-0.54	-0.72	-	-0.77	-0.90
Diluted Earnings Per Share	25.00%-0.54	-0.72	-	-0.77	-0.90